The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
The induction of differentiation in teratocarcinoma stem cells by retinoic acid
Strickland, S., & Mahdavi, V. (1978) · Cell · doi:10.1016/0092-8674(78)90008-9 · Cited by 1,420
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Self-citationde Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Self-citationAcute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z.-Y., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,277
Self-citationCastaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1704.1704 · Cited by 1,184
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
Melnick, A., & Licht, J. D. (1999) · Blood · doi:10.1182/blood.v93.10.3167.410k44_3167_3215 · Cited by 1,028
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
Sanz, M. A., Grimwade, D., Tallman, M. S., Lowenberg, B., Fenaux, P., Estey, E. H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., et al. (2009) · Blood · doi:10.1182/blood-2008-04-150250 · Cited by 947
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 879
Chen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
Self-citationPML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M.-C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 847
Di Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Zhang, X.-W., Yan, X.-J., Zhou, Z.-R., Yang, F.-F., Wu, Z.-Y., Sun, H.-B., Liang, W.-X., Song, A.-X., Lallemand-Breitenbach, V., Jeanne, M., et al. (2010) · Science · doi:10.1126/science.1183424 · Cited by 785
Self-citationChen, G., Shi, X., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z., Ni, J.-H., Shi, G., Jia, P.-M., et al. (1997) · PubMed · Cited by 781
Self-citationWarrell, R. P., de The, H., Wang, Z.-Y., & Degos, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290307 · Cited by 776
He, L.-Z., Figueiredo-Pontes, L. L., Rego, E. M., & Pandolfi, P. P. (2015) · Encyclopedia of Cancer · doi:10.1007/978-3-662-46875-3_63 · Cited by 766
Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 734
Self-citationThe Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Di Fiore, P. P., & Pelicci, P. G. (2009) · Cell · doi:10.1016/j.cell.2009.06.048 · Cited by 696
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
Drané, P., Ouararhni, K., Depaux, A., Shuaib, M., & Hamiche, A. (2010) · Genes & Development · doi:10.1101/gad.566910 · Cited by 669
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Chen, Z., Brand, N. J., Chen, A., Chen, S. J., Tong, J. H., Wang, Z. Y., Waxman, S., & Zelent, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05757.x · Cited by 640
Self-citationMolecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Cancer stem cells: lessons from leukemia
Wang, J. C. Y., & Dick, J. E. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.07.004 · Cited by 615
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Alvarez, R., Schiavone, E. M., Ferrara, F., Bresciani, F., et al. (2005) · Nature Medicine · doi:10.1038/nm1161 · Cited by 610
Shen, Z.-X., Shi, Z.-Z., Fang, J., Gu, B.-W., Li, J.-M., Zhu, Y.-M., Shi, J.-Y., Zheng, P.-Z., Yan, H., Liu, Y.-F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400053101 · Cited by 583
Self-citationThe transcriptional role of PML and the nuclear body
Zhong, S., Salomoni, P., & Pandolfi, P. P. (2000) · Nature Cell Biology · doi:10.1038/35010583 · Cited by 577
Breitman, T., Collins, S., & Keene, B. (1981) · Blood · doi:10.1182/blood.v57.6.1000.1000 · Cited by 571
The Role of PML in Tumor Suppression
Salomoni, P., & Pandolfi, P. P. (2002) · Cell · doi:10.1016/s0092-8674(02)00626-8 · Cited by 566
Lallemand-Breitenbach, V., & de The, H. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000661 · Cited by 563
Pml is essential for multiple apoptotic pathways
Wang, Z.-G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/3073 · Cited by 558
He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 557
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
PML targeting eradicates quiescent leukaemia-initiating cells
Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G., Ikeda, Y., Rosenblatt, J., Avigan, D. E., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07016 · Cited by 538
The SUMO Pathway Is Essential for Nuclear Integrity and Chromosome Segregation in Mice
Nacerddine, K., Lehembre, F., Bhaumik, M., Artus, J., Cohen-Tannoudji, M., Babinet, C., Pandolfi, P. P., & Dejean, A. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.10.007 · Cited by 535
The Mechanisms of PML-Nuclear Body Formation
Shen, T. H., Lin, H.-K., Scaglioni, P. P., Yung, T. M., & Pandolfi, P. P. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.013 · Cited by 518
Insinga, A., Monestiroli, S., Ronzoni, S., Gelmetti, V., Marchesi, F., Viale, A., Altucci, L., Nervi, C., Minucci, S., & Pelicci, P. G. (2005) · Nature Medicine · doi:10.1038/nm1160 · Cited by 516
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
Lazo, G., Kantarjian, H., Estey, E., Thomas, D., O'Brien, S., & Cortes, J. (2003) · Cancer · doi:10.1002/cncr.11314 · Cited by 494
Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honoré, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1361 · Cited by 488
Self-citationA PMLRAR α transgene initiates murine acute promyelocytic leukemia
Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., & Bishop, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2551 · Cited by 434
Zhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., & de Thé, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3978 · Cited by 427
Self-citationHu, J., Liu, Y.-F., Wu, C.-F., Xu, F., Shen, Z.-X., Zhu, Y.-M., Li, J.-M., Tang, W., Zhao, W.-L., Wu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813280106 · Cited by 425
Self-citationMuindi, J., Frankel, Sr., Miller, W. J., Jakubowski, A., Scheinberg, D., Young, C., Dmitrovsky, E., & Warrell, R. J. (1992) · Blood · doi:10.1182/blood.v79.2.299.bloodjournal792299 · Cited by 408
vom Baur, E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P., & Losson, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00339.x · Cited by 399
Identification of a tumour suppressor network opposing nuclear Akt function
Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature04809 · Cited by 394
Estey, E., Garcia-Manero, G., Ferrajoli, A., Faderl, S., Verstovsek, S., Jones, D., & Kantarjian, H. (2006) · Blood · doi:10.1182/blood-2005-10-4006 · Cited by 384
Powell, B. L., Moser, B., Stock, W., Gallagher, R. E., Willman, C. L., Stone, R. M., Rowe, J. M., Coutre, S., Feusner, J. H., Gregory, J., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269621 · Cited by 382
(1982) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/68.4.589 · Cited by 376
Ravandi, F., Estey, E., Jones, D., Faderl, S., O'Brien, S., Fiorentino, J., Pierce, S., Blamble, D., Estrov, Z., Wierda, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6130 · Cited by 376
Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M., Fenaux, P., Castaigne, S., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1710.1710 · Cited by 375
Zhu, J., Gianni, M., Kopf, E., Honoré, N., Chelbi-Alix, M., Koken, M., Quignon, F., Rochette-Egly, C., & de Thé, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14807 · Cited by 372
Self-citationDegos, L., Dombret, H., Chomienne, C., Daniel, M., Miclea, J., Chastang, C., Castaigne, S., & Fenaux, P. (1995) · Blood · doi:10.1182/blood.v85.10.2643.bloodjournal85102643 · Cited by 362
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Nasr, R., Guillemin, M.-C., Ferhi, O., Soilihi, H., Peres, L., Berthier, C., Rousselot, P., Robledo-Sarmiento, M., Lallemand-Breitenbach, V., Gourmel, B., et al. (2008) · Nature Medicine · doi:10.1038/nm.1891 · Cited by 354
Self-citationGrisolano, J. L., Wesselschmidt, R. L., Pelicci, P. G., & Ley, T. J. (1997) · Blood · doi:10.1182/blood.v89.2.376 · Cited by 352
Licht, J., Chomienne, C., Goy, A., Chen, A., Scott, A., Head, D., Michaux, J., Wu, Y., DeBlasio, A., & Miller, W. J. (1995) · Blood · doi:10.1182/blood.v85.4.1083.bloodjournal8541083 · Cited by 343
Mathews, V., George, B., Lakshmi, K. M., Viswabandya, A., Bajel, A., Balasubramanian, P., Shaji, R. V., Srivastava, V. M., Srivastava, A., & Chandy, M. (2006) · Blood · doi:10.1182/blood-2005-08-3532 · Cited by 343
Acute leukemia with promyelocytic features in PML/RARα transgenic mice
He, L.-Z., Tribioli, C., Rivi, R., Peruzzi, D., Pelicci, P. G., Soares, V., Cattoretti, G., & Pandolfi, P. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5302 · Cited by 339
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Jeanne, M., Lallemand-Breitenbach, V., Ferhi, O., Koken, M., Le Bras, M., Duffort, S., Peres, L., Berthier, C., Soilihi, H., Raught, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.003 · Cited by 335
Self-citationLo-Coco, F., Avvisati, G., Vignetti, M., Breccia, M., Gallo, E., Rambaldi, A., Paoloni, F., Fioritoni, G., Ferrara, F., Specchia, G., et al. (2010) · Blood · doi:10.1182/blood-2010-03-276196 · Cited by 332
Sanz, M. A., Montesinos, P., Rayón, C., Holowiecka, A., de la Serna, J., Milone, G., de Lisa, E., Brunet, S., Rubio, V., Ribera, J. M., et al. (2010) · Blood · doi:10.1182/blood-2010-01-266007 · Cited by 328
How acute promyelocytic leukaemia revived arsenic
Zhu, J., Chen, Z., Lallemand-Breitenbach, V., & de Thé, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc887 · Cited by 321
Self-citationMuindi, J., Frankel, Sr., Miller, W. J., Jakubowski, A., Scheinberg, D., Young, C., Dmitrovsky, E., & Warrell, R. J. (1992) · Blood · doi:10.1182/blood.v79.2.299.299 · Cited by 314
Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J.-M., & Chambon, P. (1997) · Cell · doi:10.1016/s0092-8674(00)80317-7 · Cited by 308 · cited 1×
“cAMP- or RA-initiated phosphorylation of RARα-S369 recruits transcription factor IIH (TFIIH), which allows cyclin-dependent kinase 7 (CDK7) to phosphorylate another RARα site (S77), which is required for the efficient transactivation of target genes by RAR”
BackgroundCell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Viale, A., De Franco, F., Orleth, A., Cambiaghi, V., Giuliani, V., Bossi, D., Ronchini, C., Ronzoni, S., Muradore, I., Monestiroli, S., et al. (2009) · Nature · doi:10.1038/nature07618 · Cited by 305
Lallemand-Breitenbach, V., Guillemin, M.-C., Janin, A., Daniel, M.-T., Degos, L., Kogan, S. C., Michael Bishop, J., & de Thé, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1043 · Cited by 305
Self-citationPML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
Martens, J. H. A., Brinkman, A. B., Simmer, F., Francoijs, K.-J., Nebbioso, A., Ferrara, F., Altucci, L., & Stunnenberg, H. G. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.042 · Cited by 292
Oligomerization of RAR and AML1 Transcription Factors as a Novel Mechanism of Oncogenic Activation
Minucci, S., Maccarana, M., Cioce, M., De Luca, P., Gelmetti, V., Segalla, S., Di Croce, L., Giavara, S., Matteucci, C., Gobbi, A., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80321-4 · Cited by 285
How I treat acute promyelocytic leukemia
Tallman, M. S., & Altman, J. K. (2009) · Blood · doi:10.1182/blood-2009-07-216457 · Cited by 284
Zhu, D., McCarthy, H., Ottensmeier, C. H., Johnson, P., Hamblin, T. J., & Stevenson, F. K. (2002) · Blood · doi:10.1182/blood.v99.7.2562 · Cited by 274
Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
Torii, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.6037 · Cited by 272
Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
Isakson, P., Bjørås, M., Bøe, S. O., & Simonsen, A. (2010) · Blood · doi:10.1182/blood-2010-01-261040 · Cited by 268
Zheng, P.-Z., Wang, K.-K., Zhang, Q.-Y., Huang, Q.-H., Du, Y.-Z., Zhang, Q.-H., Xiao, D.-K., Shen, S.-H., Imbeaud, S., Eveno, E., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502825102 · Cited by 256
Self-citationMathews, V., George, B., Chendamarai, E., Lakshmi, K. M., Desire, S., Balasubramanian, P., Viswabandya, A., Thirugnanam, R., Abraham, A., Shaji, R. V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.5031 · Cited by 252
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
Stem cell regulation by polycomb repressors: postponing commitment
Pietersen, A. M., & van Lohuizen, M. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.004 · Cited by 248
Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia
Villa, R., Pasini, D., Gutierrez, A., Morey, L., Occhionorelli, M., Viré, E., Nomdedeu, J. F., Jenuwein, T., Pelicci, P. G., Minucci, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.009 · Cited by 247
Lin, R. J., & Evans, R. M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80322-6 · Cited by 232
Wu, X., Hawse, J. R., Subramaniam, M., Goetz, M. P., Ingle, J. N., & Spelsberg, T. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3933 · Cited by 225
Schlenk, R. F., Dohner, K., Kneba, M., Gotze, K., Hartmann, F., del Valle, F., Kirchen, H., Koller, E., Fischer, J. T., Bullinger, L., et al. (2009) · Haematologica · doi:10.3324/haematol.13378 · Cited by 210
Jing, Y., Wang, L., Xia, L., Chen, G.-Q., Chen, Z., Miller, W. H., & Waxman, S. (2001) · Blood · doi:10.1182/blood.v97.1.264 · Cited by 204
Self-citationTreatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy
Ghavamzadeh, A., Alimoghaddam, K., Ghaffari, S. H., Rostami, S., Jahani, M., Hosseini, R., Mossavi, A., Baybordi, E., Khodabadeh, A., Iravani, M., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj019 · Cited by 200
Kchour, G., Tarhini, M., Kooshyar, M.-M., El Hajj, H., Wattel, E., Mahmoudi, M., Hatoum, H., Rahimi, H., Maleki, M., Rafatpanah, H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211821 · Cited by 199
Self-citationPurton, L. E., Dworkin, S., Olsen, G. H., Walkley, C. R., Fabb, S. A., Collins, S. J., & Chambon, P. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052105 · Cited by 198
Raelson, J., Nervi, C., Rosenauer, A., Benedetti, L., Monczak, Y., Pearson, M., Pelicci, P., & Miller, W. J. (1996) · Blood · doi:10.1182/blood.v88.8.2826.bloodjournal8882826 · Cited by 197
Rego, E. M., He, L.-Z., Warrell, R. P., Wang, Z.-G., & Pandolfi, P. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180290497 · Cited by 194
Daxx: death or survival protein?
Salomoni, P., & Khelifi, A. F. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.002 · Cited by 190
Regulation of apoptosis by PML and the PML-NBs
Bernardi, R., Papa, A., & Pandolfi, P. P. (2008) · Oncogene · doi:10.1038/onc.2008.305 · Cited by 177
Camacho, L. H., Soignet, S. L., Chanel, S., Ho, R., Heller, G., Scheinberg, D. A., Ellison, R., & Warrell, R. P. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2620 · Cited by 174
Nervi, C., Ferrara, F. F., Fanelli, M., Rippo, M. R., Tomassini, B., Ferrucci, P. F., Ruthardt, M., Gelmetti, V., Gambacorti-Passerini, C. B., Diverio, D., et al. (1998) · PubMed · doi:10.1182/blood.v92.7.2244 · Cited by 169
PML nuclear bodies and apoptosis
Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J., & de Thé, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207533 · Cited by 168
Self-citationSUMO association with repressor complexes, emerging routes for transcriptional control
Garcia-Dominguez, M., & Reyes, J. C. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.07.001 · Cited by 166
Zhu, J., Lallemand-Breitenbach, V., & de Thé, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204852 · Cited by 164
Wang, K., Wang, P., Shi, J., Zhu, X., He, M., Jia, X., Yang, X., Qiu, F., Jin, W., Qian, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.045 · Cited by 162
Self-citationA sumoylation site in PML/RARA is essential for leukemic transformation
Zhu, J., Zhou, J., Peres, L., Riaucoux, F., Honoré, N., Kogan, S., & de Thé, H. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.005 · Cited by 158
Self-citationKamashev, D., Vitoux, D., & de Thé, H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032226 · Cited by 156
Two Critical Hits for Promyelocytic Leukemia
He, L.-Z., Bhaumik, M., Tribioli, C., Rego, E. M., Ivins, S. M., Zelent, A., & Pandolfi, P. P. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00111-8 · Cited by 143
El-Sabban, M. E., Nasr, R., Dbaibo, G. S., Hermine, O., Abboushi, N., Quignon, F., Ameisen, J., Bex, F., de Thé, H., & Bazarbachi, A. A. (2000) · PubMed · doi:10.1182/blood.v96.8.2849 · Cited by 139
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformationPreprint
Boukarabila, H., Saurin, A. J., Batsché, É., Mossadegh‐Keller, N., van Lohuizen, M., Otte, A. P., Pradel, J., Muchardt, C., Sieweke, M. H., & Duprez, E. (2009) · Genes & Development · doi:10.1101/gad.512009 · Cited by 138
Positive and negative regulation of granulopoiesis by endogenous RARα
Kastner, P., Lawrence, H. J., Waltzinger, C., Ghyselinck, N. B., Chambon, P., & Chan, S. H. (2001) · Blood · doi:10.1182/blood.v97.5.1314 · Cited by 135
Westervelt, P., Lane, A. A., Pollock, J. L., Oldfather, K. M., Holt, M. S., Zimonjic, D. B., Popescu, N. C., DiPersio, J. F., & Ley, T. J. (2003) · Blood · doi:10.1182/blood-2002-12-3779 · Cited by 135
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor
Insinga, A., Monestiroli, S., Ronzoni, S., Carbone, R., Pearson, M. A., Pruneri, G., Viale, G., Appella, E., Pelicci, P. G., & Minucci, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600109 · Cited by 130
Stielow, B., Sapetschnig, A., Krüger, I., Kunert, N., Brehm, A., Boutros, M., & Suske, G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.032 · Cited by 129
The tumor suppressor Pml regulates cell fate in the developing neocortex
Regad, T., Bellodi, C., Nicotera, P., & Salomoni, P. (2009) · Nature Neuroscience · doi:10.1038/nn.2251 · Cited by 128
Guibal, F. C., Alberich-Jorda, M., Hirai, H., Ebralidze, A., Levantini, E., Di Ruscio, A., Zhang, P., Santana-Lemos, B. A., Neuberg, D., Wagers, A. J., et al. (2009) · Blood · doi:10.1182/blood-2008-10-182071 · Cited by 126
Lane, A. A., & Ley, T. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00852-3 · Cited by 124
Zhang, Q., Mao, J.-H., Liu, P., Huang, Q., Lu, J., Xie, Y., Weng, L., Zhang, Y., Chen, Q., Chen, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813142106 · Cited by 122
Altucci, L., Rossin, A., Hirsch, O., Nebbioso, A., Vitoux, D., Wilhelm, E., Guidez, F., Simone, M. D., Schiavone, E. M., Grimwade, D. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3569 · Cited by 121
Classification of Heavy-Metal Toxicity by Human DNA Microarray Analysis
Kawata, K., Yokoo, H., Shimazaki, R., & Okabe, S. (2007) · Environmental Science & Technology · doi:10.1021/es062717d · Cited by 113
RXR Is an Essential Component of the Oncogenic PML/RARA Complex In Vivo
Zhu, J., Nasr, R., Pérès, L., Riaucoux, F., Honoré, N., Berthier, C., Kamashev, D., Zhou, J., Vitoux, D., Lavau, C., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.004 · Cited by 113
RAR‐independent RXR signaling induces t(15;17) leukemia cell maturation
Benoit, G., Altucci, L., Flexor, M., Ruchaud, S., Lillehaug, J., Raffelsberger, W., Gronemeyer, H., & Lanotte, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7011 · Cited by 111
Vickers, M. A., Jackson, G. H., & Taylor, P. R. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401722 · Cited by 110
A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARα to target promoters
Bruck, N., Vitoux, D., Ferry, C., Duong, V., Bauer, A., de Thé, H., & Rochette‐Egly, C. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.256 · Cited by 108
Therapy-induced PML/RARA Proteolysis and Acute Promyelocytic Leukemia Cure
Nasr, R., Lallemand-Breitenbach, V., Zhu, J., Guillemin, M.-C., & de Thé, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0209 · Cited by 105
Du, C., Redner, R. L., Cooke, M. P., & Lavau, C. (1999) · Blood · doi:10.1182/blood.v94.2.793 · Cited by 102
Koken, M. H. M., Daniel, M., Gianni’, M., Zelent, A., Licht, J. D., Buzyn, A., Minard, P., Degos, L., Varet, B. R., & de Thé, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202414 · Cited by 100
Guillemin, M.-C., Raffoux, E., Vitoux, D., Kogan, S. C., Soilihi, H., Lallemand-Breitenbach, V., Zhu, J., Janin, A., Daniel, M., Gourmel, B., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021129 · Cited by 99
Kogan, S. C., Hong, S.-H., Shultz, D. B., Privalsky, M. L., & Bishop, J. M. (2000) · Blood · doi:10.1182/blood.v95.5.1541.005k28_1541_1550 · Cited by 97
Forced retinoic acid receptor α homodimers prime mice for APL-like leukemia
Sternsdorf, T., Phan, V. T., Maunakea, M. L., Ocampo, C. B., Sohal, J., Silletto, A., Galimi, F., Beau, M. M. L., Evans, R. M., & Kogan, S. C. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.030 · Cited by 94
Casini, T., & Pelicci, P. G. (1999) · Oncogene · doi:10.1038/sj.onc.1202630 · Cited by 93
Recruitment of RXR by Homotetrameric RARα Fusion Proteins Is Essential for Transformation
Zeisig, B. B., Kwok, C., Zelent, A., Shankaranarayanan, P., Gronemeyer, H., Dong, S., & So, C. W. E. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.006 · Cited by 92
Phagocytosis, Innate Immunity, and Host–Pathogen Specificity
Henneke, P., & Golenbock, D. T. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031256 · Cited by 89
Zhu, Q., Zhang, J., Zhu, H., Shen, Y., Flexor, M., Jia, P.-M., Yu, Y., Cai, X., Waxman, S., Lanotte, M., et al. (2002) · Blood · doi:10.1182/blood.v99.3.1014 · Cited by 88
Self-citationWojiski, S. A., Guibal, F. C., Kindler, T., Lee, B. H., Jesneck, J. L., Fabian, A. J., Tenen, D. G., & Gilliland, D. G. (2009) · Leukemia · doi:10.1038/leu.2009.63 · Cited by 87
Function of RARα during the maturation of neutrophils
Kastner, P., & Chan, S. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204757 · Cited by 86
Gaillard, E., Bruck, N., Brelivet, Y., Bour, G., Lalevée, S., Bauer, A., Poch, O., Moras, D., & Rochette-Egly, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509717103 · Cited by 76
Guidez, F., Parks, S., Wong, H., Jovanovic, J. V., Mays, A. N., Gilkes, A., Mills, K., Guillemin, M.-C., Hobbs, R. M., Pandolfi, P. P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704433104 · Cited by 75
Glasow, A., Prodromou, N., Xu, K., von Lindern, M., & Zelent, A. (2005) · Blood · doi:10.1182/blood-2004-03-1074 · Cited by 68
Petti, M. C., Fazi, F., Gentile, M., Diverio, D., de Fabritiis, P., Propris, M. S. D., Fiorini, R., Spiriti, M. A. A., Padula, F., Pelicci, P. G., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0368 · Cited by 67
Hu, J., Shen, Z., Sun, G., Chen, S.-J., Wang, Z.-Y., & Chen, Z. (1999) · PubMed · Cited by 66
Self-citationWang, G., Li, W., Cui, J., et al. (2004) · Hematological Oncology · doi:10.1002/hon.728 · Cited by 65
Oncogenic K-ras cooperates with PML-RAR to induce an acute promyelocytic leukemia-like disease
Chan, I. T., Kutok, J. L., Williams, I. R., Cohen, S., Moore, S., Shigematsu, H., Ley, T. J., Akashi, K., Beau, M. M. L., & Gilliland, D. G. (2006) · Blood · doi:10.1182/blood-2006-04-015040 · Cited by 65
Tsimberidou, A. M., Tírado-Gómez, M., Andreeff, M., O'Brien, S. M., Kantarjian, H. M., Keating, M. J., Lopez‐Berestein, G., & Estey, E. H. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500463932 · Cited by 63
Akagi, T., Shih, L., Kato, M., Kawamata, N., Yamamoto, G., Sanada, M., Okamoto, R., Miller, C. W., Liang, D., Ogawa, S., et al. (2008) · Blood · doi:10.1182/blood-2007-12-130260 · Cited by 61
Li, W., Ferguson, B. J., Khaled, W. T., Tevendale, M., Stingl, J., Poli, V., Rich, T., Salomoni, P., & Watson, C. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807640106 · Cited by 58
Rice, K. L., Hormaeche, I., Doulatov, S. R., Flatow, J. M., Grimwade, D. J., Mills, K., Leiva, M., Ablain, J., Ambardekar, C., McConnell, M. J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-206524 · Cited by 56
Puccetti, E., Obradovic, D., Beißert, T., Bianchini, A., Washburn, B., Chiaradonna, F., Boehrer, S., Hoelzer, D. F., Ottmann, O. G., Pelicci, P. G., et al. (2002) · PubMed · Cited by 54
Taschner‐Mandl, S., Koesters, C., Platzer, B., Jörgl, A., Ellmeier, W., Benesch, T., & Strobl, H. (2006) · Blood · doi:10.1182/blood-2006-04-020552 · Cited by 52
Gu, Z., Wu, Y., Zhou, M., Liu, C., Xu, H., Yan, H., Zhao, Y., Huang, Y., Sun, H., & Chen, G. (2010) · Blood · doi:10.1182/blood-2010-02-267963 · Cited by 51
Acute Promyelocytic Leukemia — Weapons of Mass Differentiation
Licht, J. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmcibr0810371 · Cited by 49
How patients have benefited from mouse models of acute promyelocytic leukaemia
Lallemand-Breitenbach, V., Zhu, J., Kogan, S. C., Chen, Z., & de Thé, H. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1719 · Cited by 42
Self-citationMatsushita, H., Scaglioni, P. P., Bhaumik, M., Rego, E. M., Cai, L. F., Majid, S. M., Miyachi, H., Kakizuka, A., Miller, W. H., & Pandolfi, P. P. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050616 · Cited by 42
Muto, A., Kizaki, M., Kawamura, C., Matsushita, H., Fukuchi, Y., Umezawa, A., Yamada, T., Hata, J., Hozumi, N., Yamato, K., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402162 · Cited by 42
Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia
Quignon, F., Chen, Z., & de Thé, H. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00025-5 · Cited by 41
Self-citationCuring APL: Differentiation or Destruction?
Kogan, S. C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.012 · Cited by 41
Chapiro, É., Delabesse, É., Asnafi, V., Millien, C., Davi, F., Nugent, E., Beldjord, K., Haferlach, T., Grimwade, D. J., & Macintyre, E. A. (2006) · Blood · doi:10.1182/blood-2005-09-009977 · Cited by 36
PML-RARα and AML1–ETO translocations are rarely associated with methylation of the RARβ2 promoter
Tabe, Y., Konopleva, M. Y., Kondo, Y., Contractor, R., Jin, L., Ruvolo, V. R., Tsutsumi‐Ishii, Y., Miyake, K., Miyake, N., Ohsaka, A., et al. (2006) · Annals of Hematology · doi:10.1007/s00277-006-0148-7 · Cited by 20
Freitas, R. A. M. S., dos Santos, G. A., Teixeira, H. L. G., Scheucher, P. S., Lucena-Araujo, A. R., de Lima, A. S. G., Lima, R. S., Garcia, A. B., Jordão, A. A., Falcão, R. P., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.035 · Cited by 12
Mixed lineage leukemia translocations and a leukemia stem cell program.
Faber, J., & Armstrong, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0972 · Cited by 12
Uy, G. L., Lane, A. A., Welch, J. S., Grieselhuber, N. R., Payton, J. E., & Ley, T. J. (2010) · Blood · doi:10.1182/blood-2008-11-189282 · Cited by 11
Cited by
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Magee, J. A., Piskounova, E., & Morrison, S. J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.003 · Cited by 1,101
Unravelling cancer stem cell potential
Beck, B., & Blanpain, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3597 · Cited by 905
Natural Products in Cancer Therapy: Past, Present and Future
Huang, M., Lu, J.-J., & Ding, J. (2021) · Natural Products and Bioprospecting · doi:10.1007/s13659-020-00293-7 · Cited by 648
Metadata
- Authors
- de Thé, H., & Chen, Z.
- Venue
- Nature Reviews Cancer
- Published
- 2010-10-22
- Volume
- 10
- Issue
- 11
- Pages
- 775-783
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2052246089
- Cited by
- 488
- References
- 156
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.